The global pandemic of Coronavirus disease 2019 (COVID‐19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is an once‐in‐a‐lifetime public health …

To investigate the immune status of people who previously had COVID‐19 infections, we
recruited two‐week postrecovery patients and analyzed circulating cytokine and lymphocyte …

Accumulating evidence suggests that severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2) impairs the adaptive immune system during acute infection. Still, it remains …

Background Emerging studies indicate that some coronavirus disease 2019 (COVID-19)
patients suffer from persistent symptoms, including breathlessness and chronic fatigue; …

Objectives: To describe the clinical sequelae and immunological features of COVID-19
survivors who have been discharged from the hospital for 5-8 months. Methods: This study is …

While studies have elucidated many pathophysiological elements of COVID-19, little is
known about immunological changes during COVID-19 resolution. We analyzed immune …

Most individuals affected by COVID-19 recovered uneventfully. However, mounting
evidence reported patients with persisting symptoms (post-COVID sequelae), 1 and …

During the COVID-19 pandemic, a phenomenon emerged in which some patients with
severe disease were critically ill and could not be discharged from the ICU even though they …

Severe SARS-CoV-2 infection can trigger uncontrolled innate and adaptive immune
responses, which are commonly associated with lymphopenia and increased neutrophil …

The long-term immunity and functional recovery after SARS-CoV-2 infection have
implications in preventive measures and patient quality of life. Here we analyzed a …